352 related articles for article (PubMed ID: 2302571)
1. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
Ichikawa J; Meltzer HY
Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
[TBL] [Abstract][Full Text] [Related]
2. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis.
Ichikawa J; Meltzer HY
Eur J Pharmacol; 1990 Feb; 176(3):371-4. PubMed ID: 2184042
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
4. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action.
Lane RF; Blaha CD
Brain Res Bull; 1987 Jan; 18(1):135-8. PubMed ID: 3828839
[TBL] [Abstract][Full Text] [Related]
5. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
Ichikawa J; Meltzer HY
Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
[TBL] [Abstract][Full Text] [Related]
6. The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis.
Chai B; Meltzer HY
Neurosci Lett; 1992 Jun; 140(1):47-50. PubMed ID: 1383891
[TBL] [Abstract][Full Text] [Related]
7. Apomorphine decreases stimulated dopamine release in rat nucleus accumbens but not in neostriatum: in vivo voltammetric data.
Stamford JA; Kruk ZL; Millar J
Eur J Pharmacol; 1987 Jul; 139(3):363-4. PubMed ID: 3666014
[No Abstract] [Full Text] [Related]
8. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis.
Hernandez L; Hoebel BG
Brain Res Bull; 1989 Apr; 22(4):763-9. PubMed ID: 2736403
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
10. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.
Spampinato U; Girault JA; Danguir J; Savaki HE; Glowinski J; Besson MJ
Brain Res Bull; 1986 Feb; 16(2):161-6. PubMed ID: 3697784
[TBL] [Abstract][Full Text] [Related]
11. Dopamine release in the nucleus accumbens of freely moving rats determined by on-line dialysis: effects of apomorphine and the neuroleptic-like peptide desenkephalin-gamma-endorphin.
Radhakishun FS; Westerink BH; van Ree JM
Neurosci Lett; 1988 Jul; 89(3):328-34. PubMed ID: 2901702
[TBL] [Abstract][Full Text] [Related]
12. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
Karoum F; Chrapusta SJ; Egan MF
J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
[TBL] [Abstract][Full Text] [Related]
13. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
Imperato A; Di Chiara G
J Pharmacol Exp Ther; 1986 Oct; 239(1):219-28. PubMed ID: 3761194
[TBL] [Abstract][Full Text] [Related]
14. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis.
Westerink BH; Tuntler J; Damsma G; Rollema H; de Vries JB
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):502-7. PubMed ID: 3501841
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo.
Blaha CD; Lane RF
Neurosci Lett; 1987 Jul; 78(2):199-204. PubMed ID: 2888060
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry.
Lane RF; Blaha CD; Rivet JM
Brain Res; 1988 Sep; 460(2):398-401. PubMed ID: 2852047
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic antagonists attenuate neurotensin-stimulated accumbens and striatal dopamine metabolism.
Rivest R; Marsden CA
Neuroscience; 1992; 47(2):341-9. PubMed ID: 1641127
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
Imazu Y; Kobayashi K; Shohmori T
Neurochem Res; 1989 May; 14(5):459-64. PubMed ID: 2747836
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
Rivest R; Marsden CA
Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment.
Lane RF; Blaha CD; Phillips AG
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):291-9. PubMed ID: 2819952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
